CORRIGENDUM.

Abstract

Clinical and Translational MedicineVolume 11, Issue 3 e344 CORRIGENDUMOpen Access CORRIGENDUM This article corrects the following: Improving transgene expression and CRISPR-Cas9 efficiency with molecular engineering-based molecules Hengji Zhan Mengting Ding Qun Zhou Aolin Li Zhiming Cai Weiren Huang Yuchen Liu Volume 10Issue 6Clinical and Translational Medicine First Published online: October 4, 2020 First published: 04 March 2021 https://doi.org/10.1002/ctm2.344AboutSectionsPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinked InRedditWechat Two authors, Mengting Ding and Qun Zhou were added to Zhan et al.1 The author byline would thus read: Hengji Zhan1,2,†, Mengting Ding1,2,†, Qun Zhou1,2,†, Aolin Li1,2,†, Zhiming Cai1,2, Weiren Huang1,2,Yuchen Liu1,2 In addition, the following should be added as a footnote: †Hengji Zhan, Mengting Ding, Qun Zhou, and Aolin Li contributed equally to this work The online version of this article was corrected. The authors regret these errors. REFERENCE 1Zhan H, Cai Z, et al. Improving transgene expression and CRISPR-Cas9 efficiency with molecular engineering-based molecules. Clin Transl Med. 2020; 10:e242. Google Scholar Volume11, Issue3March 2021e344 ReferencesRelatedInformation